ESC 365 - How to identify very high cardiovascular risk patients and their therapeutic approach.

ESC Premium Access

How to identify very high cardiovascular risk patients and their therapeutic approach.

Session: How to facilitate the management and improve outcomes in patients after a cardiovascular event, is the cardiovascular polypill the answer?

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor D. Grobbee (Utrecht, NL)

Sponsored by Ferrer

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Diederick E Grobbee

University Medical Center Utrecht, Utrecht (Netherlands (The))

40 presentations

11 followers

3 more presentations in this session

The relationship between adherence to medication and cardiovascular outcomes: MINERVA study.

Speaker: Doctor J. Castellano Vazquez (Madrid, ES)

New therapeutic strategy in secondary prevention: The Societies consensus on polypill management.

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)

The Cardiovascular Polypill, an opportunity for a new therapeutic approach.

Speaker: Doctor V. Fuster (New York, US)

Access the full session

How to facilitate the management and improve outcomes in patients after a cardiovascular event, is the cardiovascular polypill the answer?

Speakers: Professor D. Grobbee, Doctor J. Castellano Vazquez, Professor J. Gonzalez Juanatey, Doctor V. Fuster

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources